Malaria is a disease of public health importance in many parts of the world. Currently, there is no effective way to eradicate malaria, so developing safe, efficient, and cost-effective vaccines against this disease remains an important goal. Current research on malaria vaccines is focused on developing vaccines against pre-erythrocytic stage parasites and blood-stage parasites or on developing a transmission-blocking vaccine. Here, we briefly describe the progress made towards a vaccine against , the most pathogenic of the malaria parasite species to infect humans.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794966 | PMC |
http://dx.doi.org/10.1155/2019/9751471 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!